Article Text
Abstract
Lyme disease is one of the most controversial illnesses in the history of medicine. In 2006 the Connecticut Attorney General launched an antitrust investigation into the Lyme guidelines development process of the Infectious Diseases Society of America (IDSA). In a recent settlement with IDSA, the Attorney General noted important commercial conflicts of interest and suppression of scientific evidence that had tainted the guidelines process. This paper explores two broad ethical themes that influenced the IDSA investigation. The first is the growing problem of conflicts of interest among guidelines developers, and the second is the increasing centralisation of medical decisions by insurance companies, which use treatment guidelines as a means of controlling the practices of individual doctors and denying treatment for patients. The implications of the first-ever antitrust investigation of medical guidelines and the proposed model to remediate the tainted IDSA guidelines process are also discussed.
Statistics from Altmetric.com
Footnotes
Competing interests: RBS serves without compensation on the medical advisory panel for QMedRx Inc. He has no financial ties to the company.
Provenance and peer review: Not commissioned; externally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Read the full text or download the PDF:
Other content recommended for you
- Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism
- Lyme disease in the United Kingdom
- Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years ' experience at a UK centre
- US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
- Treatment strategies for cerebrospinal shunt infections: a systematic review of observational studies
- Antimicrobial stewardship programmes: bedside rationing by another name
- Vancomycin dosing in children: what is the question
- Constraining the use of antibiotics: applying Scanlon 's contractualism
- Physician antibiotic prescriptions for skin infections in the outpatient setting are often unnecessarily long and include unnecessary antibiotics
- Antimicrobial resistance and antimicrobial stewardship programmes: benefiting the patient or the population